The Glow Blend
GHK-Cu focused blend for collagen synthesis and tissue remodeling research.
Mechanism of Action
Bioregulator compound with targeted biochemical activity.
Evidence Chain
The Glow Blend
COMPOUND
2 Research Goals
• Anti-Aging & Longevity
• Skin & Cosmetic
Evidence Strength
1 article sourced
Knowledge Graph
(3 connections)Research Goals
(2)Overview
The Glow Blend is a GHK-Cu focused blend designed for collagen synthesis and tissue remodeling research. This stack centers on the copper peptide GHK-Cu, one of the most extensively studied peptides in skin and tissue regeneration, combined with complementary peptides that support skin health, wound healing, and connective tissue integrity. The blend is designed for research applications in skin rejuvenation, wound healing, and aesthetic tissue remodeling.
Mechanism of Action
The Glow Blend centers on GHK-Cu, which modulates the expression of over 4,000 human genes, upregulating collagen, elastin, and glycosaminoglycan synthesis while downregulating inflammatory and oxidative stress genes. GHK-Cu stimulates fibroblast proliferation, promotes angiogenesis, and activates superoxide dismutase (SOD) for antioxidant defense. The copper ion component is essential for lysyl oxidase activity, which cross-links collagen and elastin. Complementary peptides in the blend may support additional aspects of skin health and tissue remodeling through mechanisms including wound healing promotion and inflammation modulation.
Research Highlights
GHK-Cu has demonstrated significant efficacy in skin regeneration research, with studies showing improved elasticity, reduced wrinkles, enhanced barrier function, and accelerated wound healing. Research has shown hair growth stimulation comparable to minoxidil in some models. Studies have explored GHK-Cu's potential in bone regeneration, neuroprotection, and anti-cancer applications. The combination approach is designed to leverage complementary mechanisms for comprehensive skin and tissue health support. Research on the specific combination is limited, with most data derived from individual component studies.
Dosage & Administration
As a research blend, dosing protocols are not standardized. GHK-Cu has been used topically at 0.05-3% concentrations and via subcutaneous injection at 1-5 mg per day in research. For research use only (RUO).
Safety Profile
GHK-Cu has demonstrated excellent safety profiles in preclinical and clinical studies, with a long history of use in cosmetic applications. The combination may produce additive or synergistic effects. Full safety characterization of the combination is pending. Not approved by the FDA for any specific medical indication (approved for cosmetic use).
References
Pickart L, et al. GHK-Cu and skin. Adv Wound Care. 2015. Pickart L, et al. GHK and gene expression. J Biomater Sci Polym Ed. 2012. Refer to individual component references. All content is for educational and research purposes only.
Related Compounds
Synergy & Compatibility
(5)Computational assessment of bio-regulatory compatibility with compounds sharing research goals. Scores reflect half-life alignment, receptor target overlap, and bioavailability data.
Computational assessment based on available pharmacology data. Does not account for individual variability, dose-dependent effects, or unstudied interactions. For research use only.
Community Observations
(0)Qualitative, self-reported researcher observations. Distinct from peer-reviewed evidence — not medical advice.
No approved observations yet. Sign in to contribute.
For research use only. Not medical advice.